Table 2 General information of patients
From: Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis
Frequency | Percent | |
|---|---|---|
Gender | ||
Female | 112 | 50.7 |
Male | 109 | 49.3 |
Age group | ||
≤30 | 17 | 7.7 |
30–55 | 133 | 60.2 |
≥55 | 71 | 32.1 |
Child-Pugh Classification | ||
A | 157 | 71.0 |
B | 64 | 29.0 |
Etiology of liver cirrhosis | ||
Hepatitis B | 196 | 88.7 |
Hepatitis C | 25 | 11.3 |
BCLC stage | ||
A | 29 | 13.1 |
B | 123 | 55.7 |
C | 69 | 31.2 |
History of vomiting | ||
No | 181 | 81.9 |
Yes | 40 | 18.1 |
Kinetosis | ||
No | 177 | 80.1 |
Yes | 44 | 19.9 |
Smoking history | ||
No | 179 | 81.0 |
Yes | 42 | 19.0 |
Alcohol history | ||
No | 172 | 77.8 |
Yes | 49 | 22.2 |
Use of analgesics | ||
No | 157 | 71.0 |
Yes | 64 | 29.0 |
Chemotherapeutic drugs | ||
Lobaplatin | 109 | 49.3 |
Epirubicin | 112 | 50.7 |
Dosage of Lipiodol | ||
< 5 ml | 81 | 36.7 |
5-10 ml | 85 | 38.5 |
> 10 ml | 55 | 24.9 |
Limosis before operation | ||
No | 110 | 49.8 |
Yes | 111 | 50.2 |
Postoperative pain | ||
No | 112 | 50.7 |
Yes | 109 | 49.3 |